IGFL1P1 and esophageal cancer: In contrast, IGFL1P1, LRRC57A-AS1, SNHG3, ULK3 and ZFYVE19 showed poor expression in esophageal cancer tissues but high expression in the combined treatment group (Supplementary Fig. 6B).